Table 3.
Demographic and comorbidities of matched cohort, n = 79,734.
| Demographics | Not Screened (n = 61,036) | DOISNORE50 (n = 18,698) | P |
|---|---|---|---|
| Age, mean (SD) | 55.81 (20.9) | 61.2 (15.8) | .292 |
| Male, n (%) | 28,883 (47.3%) | 8,281 (44.3%) | < .001 |
| Race, n (%) | < .001 | ||
| White | 44,237 (72.5%) | 14,913 (79.8%) | |
| Black | 11,780 (19.3%) | 2,907 (15.5%) | |
| Other | 5,019 (8.2%) | 878 (4.7%) | |
| BMI > 32, n (%) | 11,265 (23.4%) | 4,512 (24.1%) | .284 |
| OSA, AHI ≥ 5 events/h, n (%) | 301 (0.5%) | 112 (0.6%) | .361 |
| Comorbidity | n (%) | P | |
| Hypercapnia | 2,540 (4.2%) | 353 (1.9%) | .133 |
| AIDS | 306 (0.5%) | 62 (0.3%) | .026 |
| CVA | 5,395 (8.8%) | 886 (4.7%) | .164 |
| CHF | 8,560 (14%) | 1,916 (10.2%) | .071 |
| Pulmonary disorder | 12,816 (21%) | 3,676 (19.7%) | .033 |
| Afib | 6,317 (10.3%) | 2,201 (11.8%) | .045 |
| COPD | 9,976 (16.3%) | 3,965 (21.2%) | .125 |
| DM | 10,757 (17.6%) | 2,858 (15.3%) | .063 |
| Tumor Malignancy | 2,390 (3.9%) | 1,656 (8.9%) | .202 |
| Liver Disorder | 1,946 (3.2%) | 357 (1.49%) | .081 |
| MI | 5,605 (9.2%) | 1,267 (6.8%) | .011 |
Demographics and comorbidities of 61,036 patients not screened and 18,698 patients screened with DOISNORE50. Afib = atrial fibrillation, AHI = apnea-hypopnea index, AIDS = acquired immunodeficiency syndrome, BMI = body mass index, CHF = congestive heart failure, COPD = chronic obstructive pulmonary disease, CVA = cerebrovascular accident, DM = type 2 diabetes mellitus, MI = myocardial infarction, OSA = obstructive sleep apnea, SD = standard deviation.